Der Urologe最新文献_第5页

Termine

Der Urologe Pub Date : 2020-01-01 DOI: 10.1007/s00120-019-01101-y

引用次数: 0

[Rate of thrombosis and bleeding after urological surgery under standardized anticoagulation]. [标准化抗凝治疗下泌尿外科术后血栓及出血发生率]。

Der Urologe Pub Date : 2020-01-01 DOI: 10.1007/s00120-019-01045-3

S K Morische, M W Kramer, A S Merseburger, F Gieseler, J Cordes

{"title":"[Rate of thrombosis and bleeding after urological surgery under standardized anticoagulation].","authors":"S K Morische, M W Kramer, A S Merseburger, F Gieseler, J Cordes","doi":"10.1007/s00120-019-01045-3","DOIUrl":"10.1007/s00120-019-01045-3","url":null,"abstract":"Background: According to the current definition of the German guideline for prevention of venous thromboembolism, urological surgery includes a high number of high-risk patients. All patients undergoing urological surgery between 2012 and 2016 were analyzed with regard to complications (bleeding or thrombosis).Materials and methods: This study is a retrospective and monocentric cohort study. Included were all patients who underwent surgery between 2012 and 2016 at the Urological Department at the University Hospital of Luebeck. Information was collected relating to anticoagulation, patient-specific and surgery-specific risk factors, and complications.Results: In all, 3609 surgeries were analyzed: 77.8% of patients received no medical prophylaxis, 10.2% received an aggregation inhibitor, and 8.5% synthetic, unfractionated or low molecular weight heparin. Heparin was administered to 80.4% of patients after surgery. During an average hospital stay of 4.5 days, 93.3% of the patients received no change in anticoagulation. Merely 0.8% of all patients suffered from clinical thomboembolic events within 28 days. In contrast the number of bleedings was higher with 20.3% (minor: 4.8%, major: 15.5%).Conclusion: We found a slight risk for postoperative thromboembolism (0.8%). The risk for postoperative bleeding in contrast was 20.3%, including 15.5% major bleedings. The results are discussed in relation to the current guidelines.","PeriodicalId":11122,"journal":{"name":"Der Urologe","volume":"10 1","pages":"40-51"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74582778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology]. [使用合成吊带和网状植入物治疗女性压力性尿失禁和脱垂：德国泌尿学会泌尿功能诊断和女性泌尿学工作组的声明]。

Der Urologe Pub Date : 2020-01-01 DOI: 10.1007/s00120-019-01074-y

K Höfner, C Hampel, R Kirschner-Hermanns, S H Alloussi, R M Bauer, S Bross, T Bschleipfer, M Goepel, A Haferkamp, T Hüsch, A Kaufmann, G Kiss, J Kranz, M Oelke, J Pannek, A Reitz, M Rutkowski, W Schäfer, H Schulte-Baukloh, S Schumacher, C Seif, D Schultz-Lampel

{"title":"[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].","authors":"K Höfner, C Hampel, R Kirschner-Hermanns, S H Alloussi, R M Bauer, S Bross, T Bschleipfer, M Goepel, A Haferkamp, T Hüsch, A Kaufmann, G Kiss, J Kranz, M Oelke, J Pannek, A Reitz, M Rutkowski, W Schäfer, H Schulte-Baukloh, S Schumacher, C Seif, D Schultz-Lampel","doi":"10.1007/s00120-019-01074-y","DOIUrl":"10.1007/s00120-019-01074-y","url":null,"abstract":"Due to a safety alert issued by the US Food and Drug Administration (FDA) in 2011 for transvaginal mesh implants to treat female prolapse as a result of numerous reports of complications such as infection, chronic pain, dyspareunia, vaginal erosion, shrinkage and erosion into other organs nearly all industrial products have been withdrawn from the market in the meantime. The United Kingdom, Australia, and New Zealand extended warnings and prohibitions even on the implantation of midurethral slings (TVT, TOT). In view of these current international controversies regarding the use of implanted materials for the treatment of stress incontinence and prolapse and the lack of clear guidelines for the use of biomaterials, the opinion of the Working Group on Urological Functional Diagnostics and Female Urology should provide clarity. The Opinion is based on the SCENIHR Report of the \"European Commission's Scientific Committee on Emerging and Newly Identified Health Risks\", the \"Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence\" and in compliance with relevant EAU and national guidelines and the opinion of the Association for Urogynaecology and Plastic Pelvic Floor Reconstruction (AGUB eV). In addition, recommendations are given for the future handling of implants of slings and meshes for the treatment of stress incontinence and prolapse from a urologic viewpoint.","PeriodicalId":11122,"journal":{"name":"Der Urologe","volume":"49 1","pages":"65-71"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79984537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dank an die Gutachterinnen und Gutachter 2019

Der Urologe Pub Date : 2020-01-01 DOI: 10.1007/s00120-019-01087-7

引用次数: 0

AR-V7 als prädiktiver Biomarker für das Prostatakarzinom – „more than just prophecy?“ 明显的前列腺肿瘤征兆"

Der Urologe Pub Date : 2019-12-09 DOI: 10.1007/s00120-019-01086-8

C. Bernemann, L. Krabbe

引用次数: 0

Mitteilungen der DGU 英美情报

Der Urologe Pub Date : 2019-12-01 DOI: 10.1007/s00120-019-01082-y

Mitteilungen der Dgu, Die DGU-KOLUMNE, W. Bühmann, Früherkennung von Hodenkrebs

引用次数: 0